Replies to post #8051 on RespireRx Pharmaceuticals Inc (fka RSPI)

[meixatech]

But, remember that COR has a license agreement with the University of California who holds the patents for the ampakines (at least those developed at UCI) and we do not know what that agreement is. There could be a “poison pill” clause which would prevent outright sale of COR. So, I would guess that any BP purchase must have the blessing of UC.

[gfp927z]

Money4, Concerning a buyout, the chances have gotten a lot better with Servier out of the picture, and with Organon's Ampakine interests now being owned by Schering. The fragmentation of Ampakine rights/territories was a key roadblock to potential BP buyout interest. Now Cortex owns the entire global Neurodegenerative rights again, and the Schizo/Depression rights owned by Schering may also be available for acquisition by a BP. These factors, combined with CX-717/ADHD looking like a very hot property again, make the buyout scenario considerably more likely.